Global Type 2 Diabetes Market
Healthcare Services

Type 2 Diabetes Market Growth Outlook: Trends, Market Size, and Opportunities Over the Next Decade

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Factors Are Propelling the Market Growth of theType 2 Diabetes Market from 2025 to 2034?

The growth of the type 2 diabetes market is anticipated to be driven by the rising rates of obesity and heart diseases. Obesity, defined as a medical condition where excessive body fat has accumulated to detrimental levels, and heart disease, which includes any disorder that affects the heart and blood vessels, add to the surge in type 2 diabetes. Overweight conditions increase insulin resistance, leading to higher blood sugar levels and consequentially developing into type 2 diabetes. Conversely, elevated blood sugar levels can harm blood vessels and nerves controlling the heart and blood flow, resulting in heart diseases. For example, in March 2024, the World Health Organization, a Switzerland-based intergovernmental organization, stated that about one-eighth of the world’s population was dealing with obesity. This included 2.5 billion adults aged 18 years and above, 890 million of whom were obese. Among adults, 43% were overweight, and 16% were considered obese. Furthermore, the count of overweight children below 5 years reached 37 million. Hence, the surging rates of obesity and heart diseases are augmenting the growth of the type 2 diabetes market. Type 2 Diabetes Market Driver: Expanding Elderly Population Boosts Type 2 Diabetes Market Growth

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13050&type=smp

How Will the Growth Rate of theType 2 Diabetes Market Impact Industry Trends by 2034?

In the past few years, the size of the type 2 diabetes market has witnessed a robust growth. It is projected to rise from $48.14 billion in 2024 to $51.96 billion in 2025, showcasing a compound annual growth rate (CAGR) of 7.9%. The historical growth can be traced back to factors such as changes in diet and lifestyle, an aging population, advancements in pharmaceuticals, and public health campaigns.

The market size for type 2 diabetes is projected to experience significant growth in the upcoming years, reaching $72.22 billion by 2029 with a compound annual growth rate (CAGR) of 8.6%. The anticipated growth over this period can be traced back to the worldwide spread of diabetes, individualized treatments, progress in technology, and modifications in healthcare policies. Noteworthy trends for the forecast period comprise of digital health and telemedicine, preventive measures and early intervention, artificial intelligence (AI) and machine learning (ML), and metabolic surgery.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13050

How Are Market Trends and Innovations Revolutionizing theType 2 Diabetes Industry in Recent Times?

Leading enterprises in the type 2 diabetes market are creating inventive products like Mounjaro to improve safety standards and efficacy for patients with diabetes. Drugs like Mounjaro have been designed to boost the efficiency, safety, or ease of managing diabetes in comparison to currently available medicines. Efforts to innovate in the field of diabetes medication are centered on enhancing blood sugar regulation, reducing adverse effects, and tackling other associated health issues. For example, in May 2022, US-based pharmaceutical firm Eli Lilly and Co. secured approval from the U.S. Food and Drug Administration, a United States government agency, for the injection of Mounjaro (tripeptide) to ameliorate blood sugar regulation in adults suffering from type 2 diabetes. This approval was in addition to recommendations for diet and exercise. Tirzepatide, a novel dual-targeted therapeutic approach for type 2 diabetes, is a weekly injection that affects two hormones responsible for blood sugar regulation: GLP-1 and GIP. While GLP-1 aids in augmenting insulin production and reducing glucagon production, GIP contributes to increased insulin production. Hence, Tirzepatide emerges as a potentially effective new treatment choice for people suffering from type 2 diabetes, including those who have not reacted positively to other treatment options.

Which Key Market Players Are Shaping the Future and Growth of theType 2 Diabetes Market?

Major companies operating in the type 2 diabetes market are F. Hoffmann-La Roche AG, Merck and Co. Inc., Novartis AG, AstraZeneca PLC, Abbott Laboratories, Sanofi SA, Medtronic PLC, Takeda Pharmaceutical Company, GlaxoSmithKline plc., Eli Lilly and Company, Novo Nordisk A/S, Johnson And Johnson Private Limited, Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Dexcom Inc., Amgen Inc., Insulet Corporation, Ascensia Diabetes Care, Byram Healthcare, Beta Bionics, Onduo LLC, DarioHealth, One Drop, Bigfoot Biomedical Inc., Digbi Health, MySugr GmbH, Senseonics Holdings Inc., Provention Bio Inc., Vida Health Inc., Diathrive Health.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/type-2-diabetes-global-market-report

What Are the Core Segments of the Type 2 Diabetes Market, and How Do They Contribute to Growth?

The type 2 diabetes market covered in this report is segmented –

1) By Drug Class: Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, Thiazolidinediones, Alpha-Glucosidase Inhibitors, Sulfonylureas And Other Insulin Secretagogues, Biguanides, SodiumGlucose Cotransporter 2 Inhibitors, Other Drug Classes

2) By Application: Glycemic Control, Cardiovascular Safety, Hypoglycemia Avoidance, Other Applications

3) By End-User: Children, Adults

Subsegments:

1) By Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: Sitagliptin, Saxagliptin, Linagliptin, Alogliptin

2) By Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Liraglutide, Semaglutide, Dulaglutide, Exenatide

3) By Thiazolidinediones: Pioglitazone, Rosiglitazone

4) By Alpha-Glucosidase Inhibitors: Acarbose, Miglitol

5) By Sulfonylureas And Other Insulin Secretagogues: Glimepiride, Glipizide, Glyburide

6) By Biguanides: Metformin

7) By Sodium-Glucose Cotransporter 2 Inhibitors: Canagliflozin, Dapagliflozin, Empagliflozin

8) By Other Drug Classes: Amylin Analogues, Bile Acid Sequestrants, Dopamine Agonists

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=13050&type=smp

What Regions Are Dominating the Type 2 Diabetes Market Growth?

North America was the largest region in the type 2 diabetes market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in type 2 diabetes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Type 2 Diabetes Market 2025, By The Business Research Company:

Pet Diabetes Care Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report

Smart Insulin Pens Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/smart-insulin-pens-global-market-report

Artificial Intelligence in Diabetes Management Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-diabetes-management-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Leave a Reply

Your email address will not be published. Required fields are marked *